Charles Schindler, and Mary Schindler, Individually and as Next Friend of Karl Michael Schindler v. United States

661 F.2d 552, 1981 U.S. App. LEXIS 16990
CourtCourt of Appeals for the Sixth Circuit
DecidedOctober 9, 1981
Docket79-1725
StatusPublished
Cited by30 cases

This text of 661 F.2d 552 (Charles Schindler, and Mary Schindler, Individually and as Next Friend of Karl Michael Schindler v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Charles Schindler, and Mary Schindler, Individually and as Next Friend of Karl Michael Schindler v. United States, 661 F.2d 552, 1981 U.S. App. LEXIS 16990 (6th Cir. 1981).

Opinion

BERTELSMAN, District Judge.

This is an appeal from the dismissal of a complaint and amended complaint seeking damages against the United States under the Federal Tort Claims Act. 28 U.S.C. §§ 1346(b), 2671-80 (FTCA) 1 The gravamen of the claim is that the United States negligently granted a license to a private company for the manufacture of polio vaccine according to a certain formula.

The complaints alleged that employees of the Department of Health, Education and Welfare (HEW) negligently failed to require Lederle Laboratories, a Division of American Cyanamid Company, to comply with licensing requirements of the Public Health Services Act, as amended, 42 U.S.C. § 262(d), and with the regulations promulgated pursuant thereto. The complaints further alleged that HEW employees in 1963 wrongfully granted a license to Lederle Laboratories to manufacture and distribute the product Orimune, /. e., a live, oral polio vaccine, combining Sabin vaccine strains, Types 1, 2, and 3 (“trivalent”). Vaccine manufactured in accordance with this formula, it is alleged, was in July, August and September, 1975, administered to plaintiff-appellant Karl Schindler, causing him to contract paralytic poliomyelitis in February, 1976. It is contended that by reason of this alleged negligent licensing, the United States is liable under the Federal Tort Claims Act. 2

The complaints were very carefully drawn to allege that the claimed negligence *555 of the United States consisted in failing to observe certain specific requirements of regulations previously enacted, rather than in formulating policy. 3

The reason for this approach by plaintiff was to seek to avoid the discretionary function exception of the Federal Tort Claims Act, as found in 28 U.S.C. § 2680(a), which states that the waiver of immunity for liability for tort claims against the United States does not apply to—

“(a) Any claim based upon an act or omission of an employee of the Government . . ., based upon the exercise or performance or the failure to exercise or perform a discretionary function or duty on the part of a federal agency or an employee of the Government, whether or not the discretion involved be abused.”

The trial court held that it needed to hear more evidence to determine whether the claim for relief attempted to be alleged against the United States was subject to this discretionary function exception, and declined to pass on the issue. It held, however, that as a matter of law the United States had no duty to the plaintiffs under state negligence law, which the FTCA adopts by reference. 28 U.S.C. § 1346(b). We reverse because of the latter ruling and remand for further proceedings.

The Discretionary Function Exception 4

In Downs v. United States, 5 this court held that the functions of the federal government which were immunized by the discretionary function exception were “those involving policy formulation, as distinguished from the day-to-day activities of persons not engaged in determining the general nature of the Government’s business.” That opinion extensively reviewed the legislative history of the FTCA and the decisions of the Supreme Court of the United States and lower courts interpreting it. This discussion need not be repeated here. Suffice it to say here that the “policy-making” test for determining discretionary functions under the FTCA is in accord with the weight and trend of authority, and has received general approval by the commentators. 6

*556 In the lower court and here, plaintiff has principally relied on Griffin v. United States. 7 Griffin held that the approval by an agency of the United States of a certain lot of polio vaccine in contravention of the specific requirements of applicable federal regulations was not subject to the discretionary function exception and, moreover, constituted actionable negligence per se. In reaching this holding and awarding substantial damages to the plaintiff who had contracted polio as a proximate result, as the district court found, of ingesting some of the improperly tested lot of vaccine, the Griffin courts followed the same “policy-making test” prevailing in this circuit under Downs, supra. Thus, the appellate court emphasized:

“We do not hold that the Government may be liable for policy determinations made by its officials. Rather, we hold only that the Government may be liable where its employees, in carrying out their duties, fail to conform to pre-existing statutory and regulatory requirements.” 8

Of course, it may immediately be seen that there is a factual difference between the facts alleged in the complaints in this case and those proved in Griffin. Griffin concerned the government’s negligence in testing a specific lot of vaccine, some of which the plaintiff ultimately ingested, and which proximately caused her to contract polio. This case involves the alleged negligent approval by the government of the formula for a type of polio vaccine, some of which type the plaintiff's minor is alleged to have ingested some 13 years later. What the cases have in common, at least when the matter is construed on the face of the pleadings as it must be at this stage of the proceedings, is that both approvals were allegedly granted in violation of detailed federal regulations expressly intended to provide controlling criteria.

Whether or not the obvious factual differences place this case within the discretionary function exception, the trial court did not decide. It held that further evidence would be required before it could determine whether or not policy-making functions were involved in the decision complained of. The trial court stated in its opinion granting the dismissal of the action:

“Griffin v. United States, 500 F.2d 1059 (3d Cir. 1974), is impressive authority to support the plaintiffs’ arguments on the immunity and duty issues. The government distinguishes Griffin by pointing out that in Griffin the government’s action involved the approval of a particular lot of vaccine, whereas here the government was involved in the issuance of a license.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re FTCA Flint Water Cases
E.D. Michigan, 2025
Harris v. United States
E.D. Michigan, 2025
Reynolds v. Gaughan
N.D. Ohio, 2023
Jones v. Hill
W.D. Tennessee, 2021
Morales v. United States
72 F. Supp. 3d 826 (W.D. Tennessee, 2014)
Muniz-Rivera v. United States
204 F. Supp. 2d 305 (D. Puerto Rico, 2002)
Maurello v. United States
111 F. Supp. 2d 475 (D. New Jersey, 2000)
Edward Durbin v. United States
996 F.2d 1214 (Sixth Circuit, 1993)
Lisa Huntley Flechsig v. United States
986 F.2d 1421 (Sixth Circuit, 1993)
Flechsig v. United States
991 F.2d 300 (Sixth Circuit, 1993)
Yeary v. United States
754 F. Supp. 546 (E.D. Michigan, 1991)
Frick v. United States
907 F.2d 150 (Sixth Circuit, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
661 F.2d 552, 1981 U.S. App. LEXIS 16990, Counsel Stack Legal Research, https://law.counselstack.com/opinion/charles-schindler-and-mary-schindler-individually-and-as-next-friend-of-ca6-1981.